pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,876 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: device pma×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›COMPLETEDphase readoutNCT04001946: Clinical Trial of Gastrostomy Button Securement Device

    Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Gastrostomy Complications

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07518446: Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)

    Sponsor: Amager Hospital. Phase: NA. Conditions: Atrial Fibrillation (AF), Heart Failure, Asthma (Diagnosis), Chronic Obstructive Pulmonary Disease (COPD), Diabetes, Cancer, Psychiatric Patients, Serious Medical Illness

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07519746: Satisfaction and Quality of Life Among Prosthetic Users in Gaza Governorate ,

    Sponsor: Yeditepe University. Phase: . Conditions: Amputation, Prosthesis User, Satisfaction, Quality of Lifte

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07696988: PNS to Improve Vascular Function and Limb Health in Veterans

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Lower Limb Amputees, Diabetes

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07639827: A Study of a Mental Fitness Intervention for Anesthesiology Resident Wellbeing and Self-Compassion

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Wellness, Self Compassion, Burnout, Anxiety, Depression

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03475186: Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

    Sponsor: Wake Forest University Health Sciences. Phase: PHASE2. Conditions: Glioblastoma, Radiotherapy; Complications, Cognitive Decline, Chemoradiation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06842186: A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity

    Sponsor: Wave Life Sciences USA, Inc.. Phase: PHASE1. Conditions: Overweight and Obesity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05401786: Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC

    Sponsor: The Netherlands Cancer Institute. Phase: PHASE2. Conditions: Carcinoma, Non-Small-Cell Lung

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04610086: Shared Decision Making and Satisfaction With the Diagnostic-therapeutic Process in the Shared Decision Making and Satisfaction With Colorectal Cancer Screening. The CyDESA Study

    Sponsor: Corporacion Parc Tauli. Phase: . Conditions: Colorectal Cancer, Satisfaction, Patient

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06181370: Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF

    Sponsor: Agomab Spain S.L.. Phase: PHASE1. Conditions: IPF

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07280273: Effectiveness of Pain Science Education in Patients With Fibromyalgia Syndrome Living in Rural Areas.

    Sponsor: María Catalina Osuna Pérez. Phase: NA. Conditions: Fibromyalgia Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07284069: Senicapoc and Perampanel for Newly Diagnosed Glioblastoma

    Sponsor: Aarhus University Hospital. Phase: EARLY_PHASE1. Conditions: Glioblastoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04864054: GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

    Sponsor: Eureka Therapeutics Inc.. Phase: PHASE1. Conditions: Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Neoplasm, Metastatic Liver Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07369635: A Phase III Clinical Trial Evaluating the Efficacy and Safety of TriThien Duoc Capsules in Grade II Internal Haemorrhoids Patients With Bleeding Compared to Diosmin.

    Sponsor: Hanoi Medical University. Phase: PHASE3. Conditions: Grade II Internal Hemorrhoids With Bleeding

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06719635: Management Modalities of Chronic Pelvic Pain

    Sponsor: Zagazig University. Phase: NA. Conditions: Pain, Chronic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04829617: Promoting Well-being and Health in Heart Failure

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Heart Failure, Heart Failure NYHA Class I, Heart Failure NYHA Class II, Heart Failure NYHA Class III

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06626789: Brain Signal Training to Enhance Affect Down-regulation

    Sponsor: Central Institute of Mental Health, Mannheim. Phase: PHASE1. Conditions: Borderline Personality Disorder

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07480668: Aromatherapy for Mental Health Promotion in IVF Patients

    Sponsor: Federal University of Minas Gerais. Phase: NA. Conditions: Anxiety, Stress, Depression Disorder, Quality of Life, Aromatherapy, IVF, Complementary Therapies, Spirituality, Infertility

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04341350: Comparison of an Inhaled Sedation Strategy to an Intravenous Sedation Strategy in Intensive Care Unit Patients Treated With Invasive Mechanical Ventilation

    Sponsor: University Hospital, Brest. Phase: PHASE3. Conditions: Prevention of Delirium

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT04661891: Real-time Neuromuscular Control of Exoskeletons

    Sponsor: Shirley Ryan AbilityLab. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02263274: Direct Cortical Measurement of the Intensity and Pattern of Current Flow Produced by TDCS

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Epilepsy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07640620: Relationship Between Central Sensitization and Clinical Features in Plantar Fasciitis

    Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey. Phase: . Conditions: Plantar Fasciitis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07287124: A Pivotal Study to Evaluate the Clinical Benefit, Performance and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults

    Sponsor: Cochlear. Phase: NA. Conditions: Hearing Loss, Bilateral Sensorineural

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07676682: INVESTIGATİON OF THE EFFECT OF PASSIVE UTERINE STRAIGHTENING WITH A FULL BLADDER IN COMBINATION WITH TRANSABDOMINAL ULTRASONOGRAPHY ON PREGNANCY RATES IN INTRAUTERINE INSEMINATION: A PROSPECTIVE COHORT STUDY

    Sponsor: Firat University. Phase: . Conditions: Passive Uterine Straightening

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07377682: Real-world Clinical Response to Trazodone in Italy, Poland, and Romania

    Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A. Phase: . Conditions: Depression - Major Depressive Disorder, Cognition Disorders in Old Age

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03670524: Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project

    Sponsor: University of Louisville. Phase: NA. Conditions: Cardiovascular Diseases, Metabolic Health

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06704724: A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

    Sponsor: Pfizer. Phase: PHASE1. Conditions: Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT06946680: IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG)

    Sponsor: University of Florida. Phase: PHASE1. Conditions: High-grade Glioma, Diffuse Intrinsic Pontine Glioma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06573996: The Effect of Intraoral Transcutaneous Electrical Nerve Stimulation in Orthodontics Pain

    Sponsor: University of the Pacific. Phase: NA. Conditions: Orthodontic Appliance, Pain, Transcutaneous Electric Nerve Stimulation, Orthodontic Appliance Complication

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06638996: Acute Psychological and Physiological Effects of Cannabigerol

    Sponsor: Washington State University. Phase: NA. Conditions: No Disease or Condition is Being Studied

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06650462: Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust - Study 1

    Sponsor: Old Dominion University. Phase: NA. Conditions: COVID-19, Trust

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05665062: Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With CD19+ Hematologic Malignancies

    Sponsor: Synthekine. Phase: PHASE1. Conditions: CLL/SLL, NHL, Mantle Cell Lymphoma, Follicular Lymphoma, Large B-cell Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06273046: Treatment of Fecal Incontinence and Functional Evacuation Disorders Using Non-instrumental Biofeedback

    Sponsor: Hospital Universitari Vall d'Hebron Research Institute. Phase: NA. Conditions: Fecal Incontinence, Outlet Dysfunction Constipation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07530146: Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation

    Sponsor: Helwan University. Phase: PHASE3. Conditions: The Critically Ill Patient is Requiring Intubation, Septic Shock, Pneumonia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03747627: BPF Genetics of ILD Study

    Sponsor: University of Dundee. Phase: . Conditions: Lung; Disease, Interstitial, With Fibrosis, Alveolitis, Extrinsic Allergic, Bird Fancier's Lung, Idiopathic Interstitial Pneumonias, Lung Diseases, Interstitial, Idiopathic Pulmonary Fibrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04934527: Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection

    Sponsor: University Hospital, Bordeaux. Phase: PHASE2. Conditions: Kidney Transplantation, CMV Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07639086: Sacituzumab Tirumotecan in Pts w/ NEPC After Progression on Prior Chemotherapy

    Sponsor: Virginia Commonwealth University. Phase: PHASE2. Conditions: Prostate Cancer, Neuroendocrine Prostate Cancer (NEPC)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07453342: Immune-Related Adverse Events After Cancer Immunotherapy and Safety of Treatment Rechallenge

    Sponsor: Peking Union Medical College Hospital. Phase: . Conditions: Immune-Related Adverse Events

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07356570: Second Prospective Cohort of Patients Entering the Multidisciplinary Care Pathway for Post-Covid Syndromes - SyPoCo2 Cohort

    Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Post-Acute COVID-19 Syndrome

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07338370: Relation Between Prostaglandin E2 Metabolite Levels and the Development of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates

    Sponsor: Ain Shams University. Phase: . Conditions: Neonatal Prematurity, Patent Ductus Arteriosus in Preterm Infants, Prostaglandins

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07505641: Breathing and Decision-Making (ProlEx-Context)

    Sponsor: German Institute of Human Nutrition. Phase: NA. Conditions: Breathing Techniques, Stress Management, Decision-Making

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07633769: Virtual Reality-based Rehabilitation for Traumatic Hand and Wrist Injuries

    Sponsor: University of Malaga. Phase: NA. Conditions: Wrist Injury, Hand and Upper Limb Trauma, Hand and Forearm Trauma, Muskuloskeletal Diseases

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03543969: Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

    Sponsor: H. Lee Moffitt Cancer Center and Research Institute. Phase: EARLY_PHASE1. Conditions: Melanoma (Skin), Skin Cancer, Skin Melanoma, Skin Carcinoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07416383: Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients

    Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE1. Conditions: Inflamatory Bowel Disease, Crohn Disease (CD), Ulcerative Colitis (UC)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05234983: Adapting and Evaluating a Brief Advice Tobacco Intervention in High-Reach, Low-Resource Settings in India

    Sponsor: Harvard School of Public Health (HSPH). Phase: NA. Conditions: Tobacco Use Cessation

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04332341: Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation

    Sponsor: Case Comprehensive Cancer Center. Phase: EARLY_PHASE1. Conditions: Allogeneic Hematopoietic Cell Transplantation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05153317: Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older

    Sponsor: Vertex Pharmaceuticals Incorporated. Phase: PHASE3. Conditions: Cystic Fibrosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07122817: Emotional Suppression in Elderly Individuals

    Sponsor: Istinye University. Phase: . Conditions: Elderly Person

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05669989: International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

    Sponsor: Sanofi. Phase: PHASE2. Conditions: Plasma Cell Myeloma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT06139874: Thrive Intervention in Schools

    Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Childhood Mental Disorder

    full page →ctgov ↗
    ← prev
    page 82 of 98
    next →